91¿´Ƭ

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

From
From
From
From
From
From
From
From
From
Biosimilars (September 20-21, 2027) - Product Thumbnail Image

Biosimilars (September 20-21, 2027)

  • Training
  • September 2027
  • 2 Days
  • Global
Biosimilars (March 15-16, 2027) - Product Thumbnail Image

Biosimilars (March 15-16, 2027)

  • Training
  • March 2027
  • 2 Days
  • Global
Biosimilars (October 1-2, 2026) - Product Thumbnail Image

Biosimilars (October 1-2, 2026)

  • Training
  • October 2026
  • 2 Days
  • Global
From
Oncology Biosimilars Market - Product Thumbnail Image

Oncology Biosimilars Market

  • Report
  • December 2025
  • 173 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more